‘The US FDA granted an EUA for the first CRISPR-based diagnostic test for SARS-CoV-2. CRISPR technologies have been developed for a wide variety of uses, including gene editing and gene drives. The Sherlock CRISPR SARS-CoV-2 test kit works by programming a CRISPR molecule to detect specific parts of the SARS-CoV-2 virus. Once the CRISPR system binds to its target site, a signal is released that can then be detected by researchers running the test. Sherlock stands for “Specific High-sensitivity Enzymatic Reporter unLOCKing.” With the appropriate, corresponding instrumentation, this test kit could be used at the point of care, and results can be reported within minutes.’
Download here (US FDA, May 6, 2020)
